Paper205176
Lipid peroxidation and the generation of free radicals, superoxide anion, and hydrogen peroxide in beta-lapachone-treated Trypanosoma cruzi epimastigotes.
Docampo R and 4 others. Arch Biochem Biophys, 1978. Cited by 84 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Lipid peroxidation and the generation of free radicals, superoxide anion, and hydrogen peroxide in beta-lapachone-treated Trypanosoma cruzi epimastigotes. Papers, record 205176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/205176
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipid peroxidation and the generation of free radicals, superoxide anion, and hydrogen peroxide in beta-lapachone-treated Trypanosoma cruzi epimastigotes.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipid Metabolism | Major topic |
| Naphthoquinones | Major topic |
| Peroxides | Major topic |
| Trypanosoma cruzi | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Electron Spin Resonance Spectroscopy | |
| Free Radicals | |
| Hydrogen Peroxide | |
| Kinetics | |
| Superoxides |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38474432 | In Vitro Anti-Toxoplasma Activity of Extracts Obtained from Tabebuia rosea and Tabebuia chrysantha: The Role of β-Amyrin. | Molecules | 2024 | https://conductscience.org/library/papers/38474432 | PubMed |
| 35195164 | Is the mitochondrion a promising drug target in trypanosomatids? | Mem Inst Oswaldo Cruz | 2022 | https://conductscience.org/library/papers/35195164 | PubMed |
| 34218689 | Mitochondrial Ca2+ and Reactive Oxygen Species in Trypanosomatids. | Antioxid Redox Signal | 2022 | https://conductscience.org/library/papers/34218689 | PubMed |
| 33661933 | Characterization and trypanocidal activity of a β-lapachone-containing drug carrier. | PLoS One | 2021 | https://conductscience.org/library/papers/33661933 | PubMed |
| 32095610 | Treatment of toxoplasmosis: Current options and future perspectives. | Food Waterborne Parasitol | 2019 | https://conductscience.org/library/papers/32095610 | PubMed |
| 24004461 | Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues. | BMC Microbiol | 2013 | https://conductscience.org/library/papers/24004461 | PubMed |
| 22091400 | Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones. | Mol Biol Int | 2011 | https://conductscience.org/library/papers/22091400 | PubMed |
| 21922239 | Antileishmanial, antitrypanosomal, and cytotoxic screening of ethnopharmacologically selected Peruvian plants. | Parasitol Res | 2012 | https://conductscience.org/library/papers/21922239 | PubMed |
| 21629508 | Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies. | Open Med Chem J | 2011 | https://conductscience.org/library/papers/21629508 | PubMed |
| 19924086 | The trypanocidal activity of naphthoquinones: a review. | Molecules | 2009 | https://conductscience.org/library/papers/19924086 | PubMed |
| 16304182 | Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16304182 | PubMed |
| 12417633 | A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. | J Exp Med | 2002 | https://conductscience.org/library/papers/12417633 | PubMed |
| 7641180 | Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. | Cancer Res | 1995 | https://conductscience.org/library/papers/7641180 | PubMed |
| 7008779 | Deficient metabolic utilization of hydrogen peroxide in Trypanosoma cruzi. | Biochem J | 1980 | https://conductscience.org/library/papers/7008779 | PubMed |
| 2327770 | Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327770 | PubMed |
| 2189749 | Effects of isoxazolyl-naphthoquinoneimines on growth and oxygen radical production in Trypanosoma cruzi and Crithidia fasciculata. | Experientia | 1990 | https://conductscience.org/library/papers/2189749 | PubMed |
| 376774 | Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi. | J Exp Med | 1979 | https://conductscience.org/library/papers/376774 | PubMed |
| 217340 | Effect of beta-lapachone on superoxide anion and hydrogen peroxide production in Trypanosoma cruzi. | Biochem J | 1978 | https://conductscience.org/library/papers/217340 | PubMed |
| 216177 | Ultrastructural alterations and peroxide formation induced by naphthoquinones in different stages of Trypanosoma cruzi. | Z Parasitenkd | 1978 | https://conductscience.org/library/papers/216177 | PubMed |
| 214029 | Generation of superoxide anions and hydrogen peroxide from beta-lapachone in bacteria. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/214029 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/205176
GET https://conductscience.org/api/papers/v1/205176/authors